elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58850257-e7f9bcd0-49ad-bb6e-f00f-3bdc5aa39203
Q58850257-e7f9bcd0-49ad-bb6e-f00f-3bdc5aa39203
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58850257-e7f9bcd0-49ad-bb6e-f00f-3bdc5aa39203
Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer
P6099
Q58850257-e7f9bcd0-49ad-bb6e-f00f-3bdc5aa39203
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58850257-e7f9bcd0-49ad-bb6e-f00f-3bdc5aa39203
rank
NormalRank
type
BestRank
Statement
P6099
phase I clinical trial